Andrographolide
Andrographis paniculata (Andrographolide) · also known as Andrographolide, Andrographis extract, Andrographolide
In cell and animal experiments, andrographolide can bind covalently to Cys62 of the NF-κB p50 subunit and inhibit its activation. There is no direct evidence on whether this target is occupied in humans. Human studies so far have only measured blood levels of the compound after oral dosing.
Clinical uses and human evidence
Colds: prevention and duration
Osteoarthritis pain
Mechanisms of action
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
The unsaturated lactone ring of andrographolide can covalently modify cysteine 62 of the NF-κB p50 subunit, inhibiting its activation in cell and animal experiments. Whether this target is occupied in humans has not been measured directly, and the extent of modification after oral dosing is uncertain.
Pattern recognition receptor (PRR) immune surveillance and trained immunity
Changes in markers such as lymphocyte proliferation and NK cell counts do not show that pattern recognition receptors are activated or that trained immunity develops. Some animal studies instead show reduced TLR4-related signaling, and there is currently no reliable evidence supporting this mechanism.
Safety and drug interactions
Immune stimulation
Has immunomodulating effects. Each of these stimulates immune responses. They may counteract immunosuppressant drugs, and caution is also needed during active autoimmune disease.